Company announcement no. 06 2026/27Allerød, 1 July 2026Pursuant to Matas A/S’ (Matas) Remuneration Policy, a total of 193,590 Performance Share Units (PSUs) related to the Company’s long-term incentive programme (LTIP) for 2026/27 have been granted 30 June 2026.89,892 of the PSUs have been granted…
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFULThis announcement does not constitute an offering circular, or a p…
Copenhagen, Denmark, July 1st, 2026, FinanceWireFormer McKinsey Senior Partner and Co-Leader of the Global Banking Sector joins Performativ following the company’s $14 million Series A led by Deutsche Börse GroupPerformativ, the next-generation operating system for wealth management, today announce…
1 July 2026Notification no. 52/2026Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.For further details, please find the attached template for notifications and public disclosure of transactions by persons discha…
Following approval from the Danish Competition and Consumer Authority, Erik Lytzen A/S is now part of InstallatørGruppen. Erik Lytzen A/S is a multidisciplinary installation company headquartered in Hjørring, Denmark.With this addition, InstallatørGruppen now consists of a total of 48 installation…
1 July 2026Notification no. 51/2026Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata.For further…
COPENHAGEN, Denmark, July 1, 2026 - Evaxion A/S NASDAQ:EVAX (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will present new preclinical data for vaccine candidate EVX-V1 in a poster session at the International Herpesvirus Worksh…
On March 05, 2026, Better Collective A/S initiated a share buyback program for up to 40 mEUR, to be executed from March 05, 2026, to March 03, 2027.Regulatory Release no. 58/2026The following transactions have been executed under the program:Nordea carried out the transactions mentioned above on be…
London Stock ExchangeDate:1 July 2026Issuer announcementThe Issuer, Ringkjøbing Landbobank A/S, has the 23 June 2026 carried out an early redemption of:The Issuer will apply that the bond is removed from the London Stock Exchange and the FCA’s official list.Yours faithfullyRingkjøbing Landbobank A…
Major shareholder announcementNetcompany Group A/S ("Netcompany") hereby announces the following notification received pursuant to section 38 of the Danish Capital Markets Act from Danske Bank A/S, regarding their direct and indirect holdings and voting rights in Netcompany.On 30 June 2026, Danske…
Copenhagen, Denmark, 1 July 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision cancer surgery, is pleased to share an update on the 2026 Outlook and ongoing progress. As part of this update, FluoGuide has refined timing of some milestones. The…
Ress Life InvestmentsNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.comTo:Nasdaq CopenhagenDate:30 June 2026Corporate Announcement 23/2026Ress Life Investments A/S publishes Net Asset Value (NAV).Ress Life Investments A/S publishes the Net Asset Value (NAV) per share…
Company announcement – No. 30 / 2026Total number of shares and voting rights in Zealand Pharma as of June 30, 2026Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or "the Company") NASDAQ:ZEAL (CVR-no. 20045078), a biotechnology company transforming the future of metabolic…
Company announcement No. 29 / 2026Zealand Pharma major shareholder announcement:The Capital Group Companies, Inc.Copenhagen, Denmark, June 30, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) NASDAQ:ZEAL (CVR-no. 20045078), a biotechnology company transforming the future of metabolic h…
A.P. Moller-Maersk (AMKBY) shares rose in early Copenhagen trading after the shipping company upgraded its profit outlook for this year, supported by solid demand, especially in Asia. The world's No. 2 container carrier said both underlying EBITDA and EBIT ranges were raised above analyst estimates…
With reference to Section 30 of the Danish Capital Markets Act, Gubra has received notifications from The Capital Group Companies on June 26, 2026, and June 29, 2026, respectively, regarding changes to its shareholding and voting rights position in Gubra. Following these notifications, The Capital…
Gubra A/S (the "Company") completed a capital increase on 8 June 2026 as a result of the exercise of warrants granted in 2023.In accordance with section 32 of the Danish Capital Markets Act, the Company is required to disclose the total number of voting rights and shares in the event of changes.As…
Company Announcement no. 10/2026 (June 30, 2026)Today, the Board of Directors of Konsolidator A/S has exercised part of its current authorization by issuing 150,000 warrants connected to the launch of the FP&A module. The warrants are granted as part of an employee’s remuneration package upon reach…
COPENHAGEN, Denmark, June 30, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S NASDAQ:ASND today announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. In the trial, TransCon CNP-treated childr…
PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- Researchers at the World Congress of Cutaneous Lymphoma 2026 presented two indirect treatment comparison (ITC) analyses examining the impact of mogamulizumab on long-term outcomes, including overall survival (OS), in patients with relapsed or refra…